Your browser doesn't support javascript.
loading
A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
Sautto, Giuseppe A; Kirchenbaum, Greg A; Abreu, Rodrigo B; Ecker, Jeffrey W; Pierce, Spencer R; Kleanthous, Harry; Ross, Ted M.
  • Sautto GA; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.
  • Kirchenbaum GA; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.
  • Abreu RB; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.
  • Ecker JW; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.
  • Pierce SR; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.
  • Kleanthous H; Sanofi Pasteur, Cambridge, MA 02139; and.
  • Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602; tedross@uga.edu.
J Immunol ; 204(2): 375-385, 2020 01 15.
Article en En | MEDLINE | ID: mdl-31811019

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Infecciones por Orthomyxoviridae / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Anticuerpos ampliamente neutralizantes / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Infecciones por Orthomyxoviridae / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Anticuerpos ampliamente neutralizantes / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article